Drug Information

Drug General Information
Drug ID
D0AL0S
Former ID
DIB015525
Drug Name
GSK-1362885
Synonyms
1362885
Indication Type 2 diabetes [ICD9: 250; ICD10:E11] Discontinued in Phase 1 [522855]
Company
GlaxoSmithKline plc
Target and Pathway
Target(s) Myophosphorylase Target Info Modulator [1572591]
References
Ref 522855ClinicalTrials.gov (NCT01013766) A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK1362885 in Type 2 Diabetics. U.S. National Institutes of Health.
Ref 1572591Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 2005 Aug;86(2):127-41.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.